X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Helping those affected by the 2017 hurricane season

By Holly Campbell  |    August 31, 2017
This post has been updated as of 10/30/2017 to reflect relief efforts for Hurricanes Harvey, Irma and Maria. Given the unprecedented scale of the devastation and flooding caused by Hurricanes...   Read More

SB 17 doesn’t address pressing prescription drug transparency issues for CA voters

By Priscilla VanderVeer  |    August 30, 2017
California’s SB 17 is one of a number of bills relating to prescription drug transparency around prescription medicine costs that are winding their way through U.S. statehouses.   Read More

Medicare Monday: Call for repeal of IPAB intensifies

By Nicole Longo  |    August 28, 2017
Efforts to repeal the Independent Payment Advisory Board (IPAB) are gaining momentum as health care stakeholders and policymakers on both sides of the aisle continue to voice their concerns over the...   Read More

Medicare Monday: What is the Extra Help program?

By Nicole Longo  |    August 21, 2017
Medicare Part D’s Extra Help program helps low-income beneficiaries better afford their medicines. In fact, millions of beneficiaries have received Extra Help in Part D.   Read More

Medicare Monday: Strengthening access to vaccines for seniors

By Nicole Longo  |    August 14, 2017
This month, we’re celebrating National Immunization Awareness Month! Although children may come to mind first when we think of vaccination, access to immunization is just as important for older...   Read More

Medicare Monday: Part D premiums expected to drop in 2018

By Nicole Longo  |    August 7, 2017
Great news for seniors and people living with disabilities who rely on Part D! Last week, the Centers for Medicare & Medicaid Services (CMS) announced that Medicare Part D prescription drug plan...   Read More

ICYMI: New report outlines steps for greater transparency in health care

By Katie Koziara  |    August 4, 2017
Last week, The Network for Excellence in Health Innovation (NEHI) released a new report that outlines steps for greater transparency in health care. The report states that helping consumers make...   Read More

PhRMA Supports President’s Commission’s Holistic Approach on Opioid Crisis

By Anne McDonald Pritchett, PhD  |    August 2, 2017
Just about every day, I read a news story about the opioid crisis or talk to someone who has been personally impacted by addiction. According to the CDC, opioids, including prescription opioids and...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."